ACP-196 25mg

ACP-196 is an orally available inhibitor of Bruton??s tyrosine kinase (BTK) with potential antineoplastic activity. It inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway.

Price Not Available 25mg ACP-196 25mg Supplier Page
Trivial name ACP-196 25mg
Catalog Number A15824-25
Alternative Name(s) (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
Molecular Formula C26H23N7O2
CAS# 1420477-60-6
Size 25mg
Supplier Page